SONGARDIA Trademark

Trademark Overview

On Tuesday, August 15, 2017, a trademark application was filed for SONGARDIA with the United States Patent and Trademark Office. The USPTO has given the SONGARDIA trademark a serial number of 79219376. The federal status of this trademark filing is REGISTERED as of Tuesday, September 11, 2018. This trademark is owned by Bluebird Bio (UK) Ltd. The SONGARDIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of genetic diseases
songardia

General Information

Serial Number79219376
Word MarkSONGARDIA
Filing DateTuesday, August 15, 2017
Status700 - REGISTERED
Status DateTuesday, September 11, 2018
Registration Number5557802
Registration DateTuesday, September 11, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 26, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of genetic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 28, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Namebluebird bio, Inc.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressUS
Party NameBluebird Bio (UK) Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLondon EC1A 2DY
GB
Party NameBluebird Bio (UK) Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon EC1A 2DY
GB
Party NameBluebird Bio (UK) Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC1A 2DY
GB

Trademark Events

Event DateEvent Description
Monday, December 4, 2017REFUSAL PROCESSED BY MPU
Thursday, October 26, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, October 28, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 1, 2017APPLICATION FILING RECEIPT MAILED
Thursday, November 16, 2017ASSIGNED TO EXAMINER
Saturday, November 18, 2017NON-FINAL ACTION WRITTEN
Sunday, November 19, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, December 23, 2017REFUSAL PROCESSED BY IB
Friday, March 23, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 6, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 26, 2018PUBLISHED FOR OPPOSITION
Monday, December 4, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 23, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 8, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 16, 2018ASSIGNED TO LIE
Thursday, May 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 18, 2018FINAL DISPOSITION PROCESSED
Friday, October 18, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 15, 2019NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, June 26, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 11, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, November 8, 2018CHANGE OF OWNER RECEIVED FROM IB
Tuesday, December 11, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 18, 2018FINAL DISPOSITION NOTICE SENT TO IB
Saturday, January 5, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 26, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, September 13, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, September 11, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, December 23, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB

Related Keywords

songardia genetic diseases treatment substances preparations pharmaceutical